A Moscow cluster will participate in the industrial development of drugs in collaboration with an Indian company’s unit Indian pharma major Hetero Labs has agreed with the city of Moscow to build a new plant and expand pharmaceutical collaboration in a special economic zone in the Russian capital.  A memorandum of cooperation was signed by Anatoly Garbuzov, Minister of the Moscow Government, and Murali Krishna Reddy, Director of Emerging Markets at Hetero Labs Limited, on the sidelines of the